NCT01004237已完成4 期
Additive Effects of Pravastatin and Valsartan
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 52
- 试验地点
- 1
- 主要终点
- flow-mediated dilation
研究概览
简要总结
The investigators hypothesize that pravastatin combined with valsartan may have additive effects in hypertensive, hypercholesterolemic patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 25 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hypertension and low-density lipoprotein cholesterol levels >100
排除标准
- •Overt liver disease Chronic renal failure Hypothyroidism Myopathy Uncontrolled diabetes Severe hypertension
研究组 & 干预措施
pravastatin
Active Comparator
干预措施: pravastatin, valsartan, pravastatin+valsartan (Drug)
valsartan
Active Comparator
干预措施: pravastatin, valsartan, pravastatin+valsartan (Drug)
pravastatin combined with valsartan
Active Comparator
干预措施: pravastatin, valsartan, pravastatin+valsartan (Drug)
结局指标
主要结局
flow-mediated dilation
时间窗: 8 weeks of treatment
次要结局
- insulin resistance(8 weeks of treatment)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Effect of pravastatin or fluvastatin and add-on valsartan on inflammatory markers and peripheral endothelial function in patients with acute coronary syndromepatients with NSTEMIAcute coronary syndromeEUCTR2004-003235-31-ATDiv. of Cardiology, Innsbruck Medical University80
已完成
不适用
Pleiotropic effects of pravastatin, atorvastatin, and rosuvastatin in patients with type 2 diabetes mellitus and hypercholesterolemiapatients with type 2 diabetes mellitus and hypercholesterolemiaJPRN-UMIN000007264niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine120
已完成
1 期
Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male VolunteersHypertension, HyperlipidemiaNCT01918709LG Life Sciences30
Unknown
4 期
The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina PectorisCoronary DiseaseHypercholesterolemiaNCT01325818Yokohama City University Medical Center150
已完成
3 期
Efficacy and Safety of Valsartan and the Combination of Valsartan and SimvastatinHypertensionHypercholesterolemiaDyslipidemiaNCT00385931Novartis412